PharmaPrint Inc.: The Irvine company, which develops...

PharmaPrint Inc.: The Irvine company, which develops pharmaceutical versions of herbal medicines, said it lost $2 million, or 18 cents a share, for the third fiscal quarter ended Dec. 31, compared with a net loss of $525,522, or 6 cents a share, a year ago. A net loss of $9 million, or 93 cents a share, was posted for the nine-month period, compared with a net loss of $839,014, or 10 cents a share, for the same three quarters in 1995. No revenue was reported.